Leo Cancer Care will install two upright units at the center, with the first patients set to receive care within the next two years upon FDA clearance of the technology.
“The goal of Leo Cancer Care and McLaren Proton Therapy Center’s collaboration is to bring proton therapy to more patients, and we know there are clear advantages with proton therapy,” said Stephen Towe, CEO of Leo Cancer Care.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
